Product Details:
Payment & Shipping Terms:
|
| Alias: | S-4, GTx-007;S4 | CAS: | 401900-40-1 |
|---|---|---|---|
| Assay: | 99%min | Molecular Formula: | C19H18F3N3O6 |
| Molecular Weight: | 441.36 | Appearance: | White Crystalline Powder |
| Packing: | 1kg/foil Bag | ||
| High Light: | HGH raw powder,raw sarm powder |
||
99% Purity Andarine White Powder Sarms Raw Powder S4 CAS 401900-40-1 For Muscle Building
Quick Details:
Product name: Andarine
Synonym: S-4, GTx-007;S4
CAS No.: 401900-40-1
M.F.: C19H18F3N3O6
M.W.: 441.36
Assays: 99%
Packing: 1kg/foil bag
Appearance: White crystalline powder
Andarine S4--Description:
S4 is often a form of SARM that attaches towards the androgen receptor (AR) exactly the same with regular androgens, the sole variation is always that S4 generates selective anabolic activity. S4 is a SARM with utmost androgenic effects mainly because it around 33% in the strength of testosterone when attaching to AR.
When compared with given and prohormones, Andarine won't have androgenic activity in non-skeletal muscle tissues
S4 is often a SARM with maximum potential which has a disintegration procedure for just 4 hours. It may reduce the height and width of the prostate if taken as recommended. It can be administered orally.
It's proved to be very theraputic for muscle degeneration, osteoporosis and benign prostatic hypertrophy (with bicalutamide - a non-steroidal androgen antagonist) treatment. Aside from preserving muscle mass, S4 could also help improve it.
Usage:
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects.
This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
COA:
| SARMS Raw Powder Andarine (S4) CAS401900 - 40 - 1 Great For Enhanced Vascularity | ||
| Test Items | Analysis Specifications | Results |
| Description | White crystalline powder | Conforms |
| Melting range | 129°C~132°C | 130.8°C-131°C |
| Loss on drying | ≤0.5% | 0.20 % |
| Specific rotation | -58°~-62°(C=1,in CH3OH) | -61.05° |
| Sulphated ash | ≤0.1% | 0.08 % |
| Heavy metals | ≤10ppm | Conforms |
| Chlorides | ≤0.02% | Conforms |
| SARMS Raw Powder Andarine (S4) CAS401900 - 40 - 1 Great For Enhanced Vascularity | ||
| Sulfates | ≤0.02% | Conforms |
| Fluorine | 14.7%~17.9% | 15.2% |
| Residual solvent | Methanol ≤0.2% Isopropanol ≤0.2% Ethyl acetate≤0.2% Chloroform ≤0.2% |
0.0% 0.0% 0.0% 0.0% |
| Related substances (HPLC) |
Single impurity ≤0.2% Total impurities ≤0.5% |
0.05% 0.08% |
| Assay | ≥99.5% | 99.92% |
| Conclusion |
Accordance with the reference |
|
| SARMS | |||
| 43 | Ostarine (MK-2866) | CAS: 841205-47-8 | |
| 44 | Cardarine (GW-501516) | CAS: 317318-70-0 | |
| 45 | Andarine (S4) | CAS: 401900-40-1 | |
| 46 | Ligandrol (LGD-4033) | CAS: 1165910-22-4 | |
| 47 | Ibutamoren (MK-677) | CAS: 159752-10-0 | |
| 48 | RAD140 | CAS: 118237-47-0 | |
| 49 | SR9009 | CAS: 1379686-30-2 | |
| 50 | YK11 | CAS: 431579-34-9 | |
